retatrutide fda approval status november 2025 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. Adam Will the FDA approve retatrutide?

There are going to be some people who might have a significant drug interaction, who might have a significant medical condition

The Good: Positive Results Some clients are progressing nicely while taking GLP-1s like Ozempic, Mounjaro, or Wegovy

The Bottom Line GLP-1 fatigue is real, common, and rarely talked about in detail unless youre the one collapsing into bed at four in the afternoon

Patients were followed from this 90-day landmark until the earliest occurrence of a dermatologic outcome, loss to follow-up, death, or the studys conclusion, with a maximum follow-up duration of four year

Yes, a follow-up visit within 1 to 2 weeks is recommended for most people